NMN Pioneer Revamps Skincare Line—First Launch is a Serum

Abeyoando Pharmaceutical Co., Ltd. (Headquarters: Adachi-ku, Tokyo; President: Tomotaka Abe) announces that its core NMN*¹-infused skincare product, 'NMN 13 Serum,' will be renamed 'Abeyoando 13 Serum' and feature a refreshed design starting July 2026.

There will be no changes to ingredients, formulation, price, or texture. This update involves only the product name and design.

Summary of Changes

Product Name: NMN 13 Serum → Abeyoando 13 Serum

Bottle printing design and outer packaging: Updated to a new design (bottle shape and specifications remain unchanged)

Implementation Date: Gradual shipment starting July 1, 2026

Design Concept

Inspired by the Western-style pharmacy opened by the sixth-generation head in Toranomon, the new design embodies that memory through fluid, organic curves and advanced dot patterns symbolizing continuity. The vertical infinity motif reflects the cyclical nature of tradition and innovation.

Abeyoando’s Journey with NMN

In 1731, the first-generation Abe Yōantei Sadatsuna founded the company in Edo as the personal physician to the Matsudaira family (a branch of the Tokugawa clan). Through the turbulent periods of the late Edo, Meiji, and the Great Kanto Earthquake, the Abe family has consistently focused on 'human health and wellness.'

In 2015, the tenth-generation president, Tomotaka Abe, recognized the potential of NMN. The company submitted its own safety test data to Japan’s Ministry of Health, Labour and Welfare, which contributed to the regulatory amendment on March 31, 2020, officially permitting NMN as a food ingredient. Following this, Abeyoando swiftly developed and launched NMN supplements.

Today, the company has advanced to the semifinals of the global longevity science competition 'XPRIZE Healthspan,' positioning itself at the forefront of anti-aging technology.

The 'NMN 13 Serum' is a product that elevates years of NMN research into skincare. Its formulation—featuring liposomal NMN*¹, combined with three types of human stem cell conditioned media*² and seven functional peptides*³—remains unchanged in this refresh.

*¹ Nicotinamide Mononucleotide (skin conditioning agent)

*² Human bone marrow stem cell conditioned medium, human fibroblast conditioned medium, human amniotic cell conditioned medium (all skin conditioning agents)

*³ Nicotinoyl Hexapeptide-44, Recombinant Human Polypeptide-16 (both skin protectants), Recombinant Human Polypeptide-31, Recombinant Human Polypeptide-67, Recombinant Human Polypeptide-66, Recombinant Human Oligopeptide-1, Recombinant Human Polypeptide-64 (all skin conditioning agents)

Future Developments

Currently, Abeyoando offers only serums in its skincare line. However, the company plans to launch toners and moisturizers later this summer. Without waiting for the arrival of a longevity society, the company remains committed to continuous R&D to support more users in achieving healthy beauty.

Product Overview

Product Name: Abeyoando 13 Serum (formerly NMN 13 Serum)

Type: Serum

Price: ¥12,540 (tax included, single unit)

Volume: 30mL

Release: Starting with shipments from July 1, 2026

Sales: Abeyoando Pharmaceutical Official Online Store

About Abeyoando Pharmaceutical Co., Ltd.

Since its founding in 1731, Abeyoando Pharmaceutical has integrated the wisdom of traditional Eastern medicine with insights from Western medicine to pursue health and longevity. Combining nearly 300 years of wellness philosophy with cutting-edge longevity science, the company continues its unique research and development.